Katrijn Bogman

HMG‐CoA reductase inhibitors and P‐glycoprotein modulation

Katrijn Bogman, Anne‐Kathrin Peyer, Michael Török et al. · British Journal of Pharmacology · 2001 · 192 citations · Full text

Molecular Pharmacology, Hmg‐coa Reductase Inhibitors, Aldo-keto Reductase +13

The Role of Surfactants in the Reversal of Active Transport Mediated by Multidrug Resistance Proteins

Katrijn Bogman, Françoise Erne-Brand, Jochem Alsenz et al. · Journal of Pharmaceutical Sciences · 2003 · 180 citations

Proteinlipid Interaction, Biochemistry, Multidrug Resistance Proteins +8

P-glycoprotein and surfactants: Effect on intestinal talinolol absorption

Katrijn Bogman, Y ZYSSET, Lukas Degen et al. · Clinical Pharmacology & Therapeutics · 2005 · 127 citations

Preclinical and Early Clinical Profile of a Highly Selective and Potent Oral Inhibitor of Aldosterone Synthase (CYP11B2)

Katrijn Bogman, Dietmar Schwab, Marie‐Laure Delporte et al. · Hypertension · 2016 · 97 citations · Full text

Absorption, distribution, metabolism and excretion (ADME) of the ALK inhibitor alectinib: results from an absolute bioavailability and mass balance study in healthy subjects

Peter N. Morcos, Li Yu, Katrijn Bogman et al. · Xenobiotica · 2016 · 64 citations